White H Thorax.pdf (476.07 kB)
Download file

Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice

Download (476.07 kB)
journal contribution
posted on 18.01.2017, 10:01 by Helena A. White, R. F. Miller, A. L. Pozniak, M. C. I. Lipman, Iain Stephenson, Martin J. Wiselka, Manish Pareek
Latent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies. We undertook an evaluation of UK practice, relating the responses to the local HIV/TB disease burden. 162 of 188 (86%) UK geographical areas responded; only 93/162 (57.4%) offer LTBI testing with considerable heterogeneity in practice, and no difference in HIV/TB burden between areas offering testing and those who do not. Only 33/93 (35.5%) and 6/93 (6.5%) reported full compliance with BHIVA and NICE guidance respectively. A uniform national guideline is required.

History

Citation

Thorax 2017 Feb;72(2):180-182.

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Infection, Immunity and Inflammation

Version

AM (Accepted Manuscript)

Published in

Thorax 2017 Feb;72(2):180-182.

Publisher

BMJ Publishing Group, British Thoracic Society (BTS)

issn

0040-6376

eissn

1468-3296

Acceptance date

21/09/2016

Available date

18/01/2017

Publisher version

http://thorax.bmj.com/content/early/2016/10/14/thoraxjnl-2016-209063.abstract

Language

en